Search Press releases Keywords From To 7 Sep 2022 New Three-Year BIMZELX[®]▼ (bimekizumab) Data Reinforce Long-Term Maintenance of Complete Skin Clearance in Moderate to Severe Plaque Psoriasis Read More 1 Sep 2022 UCB Showcases Strength of the Expanding Dermatology Portfolio at the 31st EADV Congress Read More 19 Aug 2022 Disposal of own shares Read More 5 Aug 2022 Transparency notification FMR LLC Read More 5 Aug 2022 Disposal of own shares Read More 28 Jul 2022 Strong first six months – UCB with continued delivery and strong resilience Read More Pagination First page Previous page Previous … Page 33 Page 34 Page 35 Page 36 Current page 37 Page 38 Page 39 Page 40 Page 41 … Page 37 of 60 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
